Delivery Order SPE2DB22D1052-SPE2DB25FU9KR
- Not listed
- The Defense Logistics Agency (DLA) awarded a $15,639.75 delivery order to AmerisourceBergen Drug Corp for the supply of BOTOX Cosmetic 100 unit vials. This competitively awarded, firm fixed-price contract with no set-aside designation is expected to be completed by October 3, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,722.72 to AmerisourceBergen Drug Corp for BOTOX 100 Unit Vials, with an ultimate completion date of August 20, 2025. This non-set-aside, firm fixed price delivery order was competitively awarded and represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor will fulfill this order from its corporate office location in...
- The Defense Logistics Agency (DLA) awarded a $4,818.00 delivery order to AmerisourceBergen Drug Corp for 200-unit vials of BOTOX on August 6, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $3,574.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Botox Cosmetic 100-unit vials, with an ultimate completion date of September 8, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,564.37 to supply Botox 200 unit vials, with an ultimate completion date of August 20, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $6,838.32 on June 18, 2025, for the supply of Botox 200 Unit Vials, with completion expected by July 11, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The award carries no set-aside designation,...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,910.65 Firm Fixed Price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 200-unit vials of BOTOX. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between DLA Troop Support Medical and Amerisourcebergen, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
- The Defense Logistics Agency awarded a delivery order valued at $3,613.50 to AmerisourceBergen Drug Corp for the supply of BOTOX 200 Unit Vials on August 8, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of BOTOX Cosmetic 100 Unit Vials, with a ceiling value of $4,021.65 and an ultimate completion date of October 10, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency (DLA) awarded a $2,584.08 delivery order to AmerisourceBergen Drug Corp for Botox 100 Unit Vials, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price contract uses no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- SPE2DB22D1052Indefinite Delivery Contract
- SPE2DB22D1052-SPE2DB25FU9KRDelivery Order
The Defense Logistics Agency (DLA) awarded a $2,624.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Botox Cosmetic 100 unit vials, with an ultimate completion date of July 11, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to military and veteran healthcare systems. The company's extensive portfolio of federal contract awards with the DLA Medical Supply Chain demonstrates its capability to fulfill diverse medical supply needs across multiple therapeutic domains. This delivery order is one of many transactions the company executes under its prime IDC, which serves Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles supporting military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 6/18/25 |